BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 19849940)

  • 1. [Hair root fragile X mental retardation protein assay for the diagnosis of fragile X syndrome].
    Luo XF; Zhong JM; Zhang XZ; Zou Y; Chen Y; Wu HP; Yu XY
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Oct; 11(10):817-20. PubMed ID: 19849940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New methods for the diagnosis of fragile X syndrome: a study of the FMRP in blood and hair].
    Ramos-Fuentes FJ
    Rev Neurol; 2001 Oct; 33 Suppl 1():S9-S13. PubMed ID: 12447812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FMRP detection assay for the diagnosis of the fragile X syndrome.
    Willemsen R; Oostra BA
    Am J Med Genet; 2000; 97(3):183-8. PubMed ID: 11449486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-brain expression analysis of FMRP in adult monkey and its relationship to cognitive deficits in fragile X syndrome.
    Zangenehpour S; Cornish KM; Chaudhuri A
    Brain Res; 2009 Apr; 1264():76-84. PubMed ID: 19368811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative measurement of FMRP in blood platelets as a new screening test for fragile X syndrome.
    Lessard M; Chouiali A; Drouin R; Sébire G; Corbin F
    Clin Genet; 2012 Nov; 82(5):472-7. PubMed ID: 21992468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular diagnosis of fragile X syndrome with polymerase chain reaction: application of a diagnostic protocol in 50 families from northern Spain].
    Durán Domínguez M; Molina Carrillo M; Fernández Toral J; Martínez Merino T; López Arístegui MA; Alvarez Retuerto AI; Onaindía Urquijo ML; Tejada Mínguez MI
    An Esp Pediatr; 2001 Apr; 54(4):331-9. PubMed ID: 11273816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive screening of fragile X syndrome A using urine and hair roots.
    Suwa K; Momoi MY
    Brain Dev; 2004 Sep; 26(6):380-3. PubMed ID: 15275700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular screening for fragile X syndrome in Thailand.
    Limprasert P; Ruangdaraganon N; Sura T; Vasiknanonte P; Jinorose U
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():114-8. PubMed ID: 11400746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical checklist for fragile X syndrome: screening of Thai boys with developmental delay of unknown cause.
    Limprasert P; Ruangdaraganon N; Vasiknanonte P; Sura T; Jaruratanasirikul S; Sriwongpanich N; Sriplung H
    J Med Assoc Thai; 2000 Oct; 83(10):1260-6. PubMed ID: 11143494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular diagnosis of Fragile X syndrome.
    Sofocleous C; Kolialexi A; Mavrou A
    Expert Rev Mol Diagn; 2009 Jan; 9(1):23-30. PubMed ID: 19099346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prader-Willi phenotype of fragile X syndrome.
    Nowicki ST; Tassone F; Ono MY; Ferranti J; Croquette MF; Goodlin-Jones B; Hagerman RJ
    J Dev Behav Pediatr; 2007 Apr; 28(2):133-8. PubMed ID: 17435464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness of a clinical test in the preselection of children with suspected fragile X syndrome].
    Fernández Carvajal I; Blanco Quirós A; Fernández Toral J; Tellería Orriols JJ; Alonso Ramos MJ; Sanz Cantalapiedra A; Martín Rodríguez JF; Palencia Luances R
    An Esp Pediatr; 2001 Apr; 54(4):326-30. PubMed ID: 11273815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fragile X syndrome: exploring its molecular basis and seeking a treatment.
    Bardoni B; Davidovic L; Bensaid M; Khandjian EW
    Expert Rev Mol Med; 2006 Apr; 8(8):1-16. PubMed ID: 16626504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplex methylation specific PCR analysis of fragile X syndrome: experience in Songklanagarind Hospital.
    Charalsawadi C; Sripo T; Limprasert P
    J Med Assoc Thai; 2005 Aug; 88(8):1057-61. PubMed ID: 16404832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FMRP expression as a potential prognostic indicator in fragile X syndrome.
    Tassone F; Hagerman RJ; Iklé DN; Dyer PN; Lampe M; Willemsen R; Oostra BA; Taylor AK
    Am J Med Genet; 1999 May; 84(3):250-61. PubMed ID: 10331602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot study for the neonatal screening of fragile X syndrome.
    Rifé M; Mallolas J; Badenas C; Tazón B; Miguélez MR; Pàmpols T; Sànchez A; Milà M
    Prenat Diagn; 2002 Jun; 22(6):459-62. PubMed ID: 12116303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The developmental roles of FMRP.
    Till SM
    Biochem Soc Trans; 2010 Apr; 38(2):507-10. PubMed ID: 20298211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exceptional good cognitive and phenotypic profile in a male carrying a mosaic mutation in the FMR1 gene.
    Govaerts LC; Smit AE; Saris JJ; VanderWerf F; Willemsen R; Bakker CE; De Zeeuw CI; Oostra BA
    Clin Genet; 2007 Aug; 72(2):138-44. PubMed ID: 17661818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blink rate in boys with fragile X syndrome: preliminary evidence for altered dopamine function.
    Roberts JE; Symons FJ; Johnson AM; Hatton DD; Boccia ML
    J Intellect Disabil Res; 2005 Sep; 49(Pt 9):647-56. PubMed ID: 16108982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragile X mental retardation syndrome: from pathogenesis to diagnostic issues.
    Mandel JL; Biancalana V
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S158-65. PubMed ID: 15135801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.